When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest

por Ehrlich, Orna, Wingate, Laura, Heller, Caren, de Melo-Martin, Inmaculada
Publicado 2019

Preferences of Adult Patients With Inflammatory Bowel Disease for Attributes of Clinical Trials: Evidence From a Choice-Based Conjoint Analysis

por Wood, Dallas, Kosa, Katherine, Brown, Derek, Ehrlich, Orna G, Higgins, Peter D R, Heller, Caren
Publicado 2019

Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease

por Szigethy, Eva M, Murphy, Sean M, Ehrlich, Orna G, Heller, Caren A, Engel-Nitz, Nicole M, Meadows, Perry, Allen, John I
Publicado 2021

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation

por Park, K T, Ehrlich, Orna G, Allen, John I, Meadows, Perry, Szigethy, Eva M, Henrichsen, Kim, Kim, Sandra C, Lawton, Rachel C, Murphy, Sean M, Regueiro, Miguel, Rubin, David T, Engel-Nitz, Nicole M, Heller, Caren A
Publicado 2020

Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation

por Scott, Frank I, Ehrlich, Orna, Wood, Dallas, Viator, Catherine, Rains, Carrie, DiMartino, Lisa, McArdle, Jill, Adams, Gabrielle, Barkoff, Lara, Caudle, Jennifer, Cheng, Jianfeng, Kinnucan, Jami, Persley, Kimberly, Sariego, Jennifer, Shah, Samir, Heller, Caren, Rubin, David T
Publicado 2022